No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer

byTeddy Guo

October 21, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read this study in the Journal of Clinical Oncology.

RELATED REPORTS

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

RelatedReports

Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Chronic Disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

January 13, 2026

Gastric bypass surgery reduces cardio-metabolic risk factors

Chronic Disease

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

October 28, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

Incidence of esophageal cancer subtypes vary drastically globally and by gender

Chronic Disease

Active Surveillance vs Standard Surgery Post-Neoadjuvant Chemoradiotherapy for Esophageal Cancer

March 24, 2025

Top 10 TV Shows to Binge Watch During Lockdown

Participation in sports and exercise linked to lower opioid use

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

#VisualAbstract Patients with advanced basal cell carcinoma who received radiation therapy are more likely to experience primary resistance to Hedgehog pathway inhibitors

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result